Dose card

This brochure provides guidance on the dosing and administration of Kerendia for adult patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). It indicates that Kerendia is used as an adjunct therapy to reduce the risk of end-stage kidney disease and cardiovascular events.

PP-KER-CA-0307-1